Reiwa 8th Fiscal Year "Program for Accelerating the Realization of Regenerative Medicine, Cell Medicine, and Gene Therapy (Basic and Applied Research Projects for Regenerative Medicine, Cell Medicine, and Gene Therapy)" Basic and Applied Research Projects (Challenge-type / Young Researcher Development Category)

Listed on GrantGunner. Last checked 17 Oct 2026.

About this grant

The National Research and Development Agency Japan Agency for Medical Research and Development (AMED) offers a program supporting basic and applied research aimed at realizing regenerative medicine, cell therapy, and gene therapy. A young researcher track has been established to support challenging research by early-career researchers, with the goal of fostering future leaders in research and development. Each project receives up to 10 million yen per year, with the implementation period running from August 2024 to the end of fiscal year 2026.

Who can apply

Eligible applicants for this project are researchers (principal investigators) who belong to domestic research institutions that meet the requirements, use such institutions as their primary research location, and are responsible for formulating research and development implementation plans as well as compiling results for the relevant R&D topics. Additionally, under the "Challenge-type/Young Researcher Development Framework," the principal investigator and co-investigators are limited to young researchers (under the age of 43 as of April 1 of the fiscal year in which the R&D begins, or within 10 years of obtaining a doctoral degree).

Browse all open grants

More grants from National Research and Development Agency, Japan Agency for Medical Research and Development